In response to the patient's question about how to know whether ...

[mynx]

In response to the patient's question about how to know whether drugs are safe, the nurse explains that all medications undergo rigorous scientific testing controlled by what organization?
 
  A) Food and Drug Administration (FDA)
  B) Drug Enforcement Agency (DEA)
  C) Centers for Disease Control and Prevention (CDC)
  D) Joint Commission on Accreditation of Healthcare Organizations (JCAHO)

Question 2

A patient diagnosed with type 1 diabetes mellitus is receiving insulin. The physician has prescribed a monoamine oxidase inhibitor (MAOI) to treat this patient's depression. What interaction will the nurse assess for with this drug combination?
 
  A) Increased risk of hypoglycemia
  B) Increased risk of hyperglycemia
  C) Increase in appetite
  D) Increased total cholesterol

[isabelt_18]

Answer to Question 1

A
Feedback:
The FDA is responsible for controlling and regulating the development and sale of drugs in the United States, allowing new drugs to enter the market only after being subjected to rigorous scientific testing. The DEA regulates and controls the use of controlled substances. The CDC monitors and responds to infectious diseases. The JCAHO is an accrediting body that inspects acute care facilities to ensure minimum standards are met.

Answer to Question 2

A
Feedback:
MAOIs can cause an additive hypoglycemic effect if taken with insulin or oral diabetic agents. This patient would have to be monitored closely and appropriate dosage adjustments made; he should be taught the importance of more frequent blood sugar monitoring. The drug combination in this question would not cause an increase in appetite or increased total cholesterol.